Mass., Oct. 2, 2007 - Generex Biotechnology Corporation (NasdaqCM:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced that the United States Patent and Trademark Office has granted the Company a new United States Patent.The patent, titled ``Metered Dose Spray Device for Use with Macromolecular Pharmaceutical Agents such as Insulin,''... Generex Biotechnology's Press Release -
